Diminazene-induced encephalopathy in dogs: Case series and treatment with crisdesalazine
Open Access
- 30 June 2025
- journal article
- Published by The Korean Society of Veterinary Service in Korean Journal of Veterinary Service
- Vol. 48 (2) , 167-172
Abstract
Yeonsoo Lee, YoungMin Yun, Woo-Jin Song. Korean J. Vet. Serv. 2025;48:167-72. https://doi.org/10.7853/kjvs.2025.48.2.167Keywords
Funding Information
- National Research Foundation of Korea (RS-2023-00252033)
- Ministry of Science and ICT, South Korea
This publication has 5 references indexed in Scilit:
- Crisdesalazine alleviates inflammation in an experimental autoimmune encephalomyelitis multiple sclerosis mouse model by regulating the immune systemBMC Neuroscience, 2025
- The Etiology, Incidence, Pathogenesis, Diagnostics, and Treatment of Canine Babesiosis Caused by Babesia gibsoni InfectionAnimals, 2022
- A review of canine babesiosis: the European perspectiveParasites & Vectors, 2016
- Use of a doxycycline-enrofloxacin-metronidazole combination with/without diminazene diaceturate to treat naturally occurring canine babesiosis caused by Babesia gibsoniActa Veterinaria Scandinavica, 2010
- The intravenous pharmacokinetics of diminazene in healthy dogsJournal of the South African Veterinary Association, 2009